At the 2026 ISPE Aseptic Conference, industry leaders will showcase how emerging digital tools, advanced automation, and modern verification techniques are transforming aseptic fill-finish operations and strengthening sterility assurance.
The shift in technology starts at the inception of aseptic system development with the application of immersive digital technologies during isolator design. In an environment where flexibility, efficiency, and compliance must coexist, isolator systems must be closely aligned with operational workflows and supported by a deep understanding of process requirements. Afton Scientific, in collaboration with SKAN, will present how virtual reality (VR) technologies were integrated into the design phase to reduce risk and deliver fit-for-purpose isolator solutions. By combining VR headsets, advanced simulation platforms, glove-tracking systems, and 3D-printed components, project teams created a realistic, interactive mock-up environment that enabled operators, engineers, and decision-makers to evaluate ergonomics, material flow, and maintenance concepts before final fabrication. Session speakers will share how this immersive approach not only improved usability and operator acceptance, but also reduced late-stage design changes and supported right-first-time project execution.
Contamination control does not stop at isolator design. Material transfer into Grade A environments remains one of the highest-risk operations in aseptic processing and a focal point of regulatory scrutiny. In response, manufacturers are increasingly implementing automated, validated, decontamination solutions to strengthen their contamination control strategies. A featured case study at the conference examines the deployment of a rapid decontamination station (RDS) for transfer into a Grade A filling isolator. Using vaporized hydrogen peroxide, the RDS enables reproducible bio-decontamination of tools, monitoring devices, and change parts prior to aseptic entry, with sterile transfer maintained through alpha-beta port connections. The system’s qualification approach and operational integration demonstrate measurable benefits, including reduced cycle time, improved utilization of isolator space, and greater flexibility during campaign production and interventions—aligned with the risk-based principles of Annex 1.
At the machine level, next-generation robotics and advanced automation are redefining performance expectations for aseptic fill-finish operations. Through strategic collaboration between pharmaceutical manufacturers and specialized equipment suppliers, fully automated platforms are now operating at speeds of up to 600 units per minute while eliminating direct human intervention through gloveless isolator concepts. These systems integrate robotics with intelligent transport architectures to deliver scalable, modular solutions with minimal operator involvement. Ready-to-use packaging components, continuous environmental monitoring, robotic telemanipulation for troubleshooting, and AI-based fault detection further enhance equipment availability and process robustness. Designed using computational fluid dynamics and validated through extensive prototyping, these platforms exemplify how digital engineering and automation can deliver both regulatory compliance and operational excellence.
As equipment becomes more automated and digitally engineered, attention increasingly shifts to verification of environmental performance, particularly airflow control in Grade A zones. Digital modeling is further advancing process development and control. Determining optimal filling parameters for parenteral products remains challenging due to product variability and diverse line configurations. Computational fluid dynamics enables rapid simulation and validation of filling behavior, while artificial intelligence builds predictive models that accelerate parameter selection. The development of digital twins of filling operations supports improved fill accuracy, reduced experimental burden, and more robust process control—capabilities increasingly aligned with modern quality-by-design strategies.
Annex 1 places strong emphasis on “first air” protection, making airflow visualization a crucial element of qualification and inspection readiness. Expectations for smoke studies have become more stringent, yet until recently, detailed guidance on execution techniques has been limited. At the 2026 ISPE Aseptic Conference, experts from the ISPE Japan Affiliate Sterile Products Processing Community of Practice and other contributors will present best practices to improve preparation, execution, and regulatory defensibility of airflow studies.
Airflow visualization must be performed during initial qualification and periodically verified under both static and dynamic conditions, with video, photo, and text documentation to demonstrate unidirectional flow and effective particle removal at critical zones. The quality of these studies depends heavily on visualization methodology, including tracer particle selection, delivery systems, illumination, and recording techniques. The ISPE Guide for Airflow Visualization, which is anticipated to be published in the second quarter of this year, provides timely and practical guidance on tracer types, tracer distributors, optimized lighting strategies, verification practices and documentation methods. A dedicated session will highlight state-of-the-art approaches, including advanced distributor designs, comparative use of propylene glycol versus water-based fogs, and laser sheet illumination to produce high-contrast, high-resolution airflow images.
These are just some of the innovations in technology and practices being showcased at the 2026 ISPE Aseptic Conference: digitally driven design, automated contamination control, intelligent production platforms, and advanced verification methodologies. By integrating immersive design tools, robotics, modeling, and airflow visualization into a unified contamination control strategy, manufacturers are building future-ready aseptic facilities that meet Annex 1 expectations while delivering flexibility, efficiency, and sustainable sterility assurance.
For anyone interested in the direction of aseptic manufacturing in 2026, and practical solutions to recent challenges, the 2026 ISPE Aseptic Conference is the place to be.
REGISTER TODAY
